Differentiation of bone marrow mesenchymal stem cells in osteoblasts and adipocytes and its role in treatment of osteoporosis

Medical Science Monitor

Volumn 22, Issue , 2016, Pages 226-233

  Wang, Cheng ^a   Meng, Haoye ^a   Wang, Xin ^b   Zhao, Chenyang ^c   Peng, Jing ^a   Wang, Yu ^a  

^a CHINESE PLA GENERAL HOSPITAL   (China)

^b LANZHOU GENERAL HOSPITAL   (China)

^c UNIVERSITY OF CHINESE ACADEMY OF SCIENCES   (China)

Author keywords

Cell transplantation; Osteoblasts; Osteoporosis; Stem cell research

Indexed keywords

BONE MORPHOGENETIC PROTEIN 2; CALCITRIOL; CHEMOKINE RECEPTOR CXCR4; ESTROGEN; FIBROBLAST GROWTH FACTOR 2; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA 2; STROMAL CELL DERIVED FACTOR 1;

ADIPOCYTE; ALLOGENEIC STEM CELL TRANSPLANTATION; ARTICLE; AUTOLOGOUS STEM CELL TRANSPLANTATION; BONE DENSITY; BONE GROWTH; BONE MARROW DERIVED MESENCHYMAL STEM CELL; BONE MASS; BONE MINERALIZATION; BONE REGENERATION; CELL DIFFERENTIATION; CELL PROLIFERATION; CYTOKINE RELEASE; HORMONE SUBSTITUTION; HUMAN; METABOLIC BONE DISEASE; NONHUMAN; OSTEOBLAST; OSTEOPOROSIS; PHYSIOTHERAPY; PULSED ELECTROMAGNETIC FIELD THERAPY; ANIMAL; BONE MARROW CELL; CYTOLOGY; MESENCHYMAL STEM CELL; MESENCHYMAL STEM CELL TRANSPLANTATION;

ADIPOCYTES; ANIMALS; BONE MARROW CELLS; CELL DIFFERENTIATION; HUMANS; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STEM CELLS; OSTEOBLASTS; OSTEOPOROSIS;

EID: 84955482974     PISSN: 12341010     EISSN: 16433750     Source Type: Journal    
DOI: 10.12659/MSM.897044     Document Type: Article

References (83)

1. Raisz LG: Pathogenesis of osteoporosis: concepts, conflicts, and prospects. J Clin Invest, 2005; 115: 3318-25.
2. Cole ZA, Dennison EM, Cooper C: Osteoporosis epidemiology update. Curr Rheumatol Rep, 2008; 10: 92-96.
3. Xia WB, He SL, Xu L et al: Rapidly increasing rates of hip fracture in Beijing, China. J Bone Miner Res, 2012; 27: 125-29.
4. Lane JM, Riley EH, Wirganowicz PZ: Osteoporosis: Diagnosis and treatment. Instr Course Lect, 1997; 46: 445-58.
5. Lewiecki EM: Treatment of osteoporosis with denosumab. Maturitas, 2010; 66: 182-86.
6. Spanou A, Lyritis GP, Chronopoulos E, Tournis S: Management of bisphos- phonate-related osteonecrosis of the jaw: A literature review. Oral Dis, 2015; 21(8): 927-36.
7. Coipeau P, Rosset P, Langonne A et al: Impaired differentiation potential of human trabecular bone mesenchymal stromal cells from elderly patients. Cytotherapy, 2009; 11: 584-94.
8. Li C, Wei G, Gu Q et al: Proliferation and differentiation of rat osteoporosis mesenchymal stem cells (MSCs) after telomerase reverse transcriptase (TERT) transfection. Med Sci Monit, 2015; 21: 845-54.
9. Bergman RJ, Gazit D, Kahn AJ et al: Age-related changes in osteogenic stem cells in mice. J Bone Miner Res, 1996; 11: 568-77.
10. Rodan GA, Harada S: The missing bone. Cell, 1997; 89: 677-80.
11. Gurevitch O, Khitrin S, Valitov A, Slavin S: Osteoporosis of hematologic etiology. Exp Hematol, 2007; 35: 128-36.
12. Bronckers AL, Sasaguri K, Engelse MA: Transcription and immunolocaliza- tion of Runx2/Cbfa1/Pebp2alphaA in developing rodent and human craniofacial tissues: Further evidence suggesting osteoclasts phagocytose os- teocytes. Microsc Res Tech, 2003; 61: 540-48.
13. Karsenty G, Ducy P, Starbuck M et al: Cbfa1 as a regulator of osteoblast differentiation and function. Bone, 1999; 25: 107-8.
14. Rodriguez JP, Garat S, Gajardo H et al: Abnormal osteogenesis in osteoporotic patients is reflected by altered mesenchymal stem cells dynamics. J Cell Biochem, 1999; 75: 414-23.
15. Rodriguez JP, Montecinos L, Rios S et al: Mesenchymal stem cells from osteoporotic patients produce a type I collagen-deficient extracellular matrix favoring adipogenic differentiation. J Cell Biochem, 2000; 79: 557-65.
16. Zhang ZM, Jiang LS, Jiang SD, Dai LY: Osteogenic potential and responsiveness to leptin of mesenchymal stem cells between postmenopausal women with osteoarthritis and osteoporosis. J Orthop Res, 2009; 27: 1067-73.
17. Nuttall ME, Gimble JM: Is there a therapeutic opportunity to either prevent or treat osteopenic disorders by inhibiting marrow adipogenesis? Bone, 2000; 27: 177-84.
18. Beresford JN, Bennett JH, Devlin C et al: Evidence for an inverse relationship between the differentiation of adipocytic and osteogenic cells in rat marrow stromal cell cultures. J Cell Sci, 1992; 102 (Pt 2): 341-51.
19. Gimble JM, Zvonic S, Floyd ZE et al: Playing with bone and fat. J Cell Biochem, 2006; 98: 251-66.
20. Boufker H, Lagneaux L, Najar M et al: The Src inhibitor dasatinib accelerates the differentiation of human bone marrow-derived mesenchymal stromal cells into osteoblasts. BMC Cancer, 2010; 10: 298.
21. Lv H, Sun Y, Zhang Y: MiR-133 is involved in estrogen deficiency-induced osteoporosis through modulating osteogenic differentiation of mesenchymal stem cells. Med Sci Monit, 2015; 21: 1527-34.
22. Yuan FL, Xu RS, Jiang DL et al: Leonurine hydrochloride inhibits osteoclas- togenesis and prevents osteoporosis associated with estrogen deficiency by inhibiting the NF-kappaB and PI3K/Akt signaling pathways. Bone, 2015; 75: 128-37.
23. Gray TK, Flynn TC, Gray KM, Nabell LM: 17 beta-estradiol acts directly on the clonal osteoblastic cell line UMR106. Proc Natl Acad Sci USA, 1987; 84: 6267-71.
24. Komm BS, Terpening CM, Benz DJ et al: Estrogen binding, receptor mRNA, and biologic response in osteoblast-like osteosarcoma cells. Science, 1988; 241: 81-84.
25. Deal C: Potential new drug targets for osteoporosis. Nat Clin Pract Rheumatol, 2009; 5: 20-27.
26. Martin A, Xiong J, Koromila T et al: Estrogens antagonize RUNX2-mediated osteoblast-driven osteoclastogenesis through regulating RANKL membrane association. Bone, 2015; 75: 96-104.
27. Rodriguez JP, Astudillo P, Rios S, Pino AM: Involvement of adipogenic potential of human bone marrow mesenchymal stem cells (MSCs) in osteoporosis. Curr Stem Cell Res Ther, 2008; 3: 208-18.
28. Kim RY, Yang HJ, Song YM et al: Estrogen modulates BMP-induced sclerostin expression via the Wnt signaling pathway. Tissue Eng Part A, 2015; 21(13- 14): 2076-88.
29. Li L, Yao XL, He XL et al: Role of mechanical strain and estrogen in modulating osteogenic differentiation of mesenchymal stem cells (MSCs) from normal and ovariectomized rats. Cell Mol Biol, 2013; Suppl.59: OL1889-93.
30. Gopalakrishnan V, Vignesh RC, Arunakaran J et al: Effects of glucose and its modulation by insulin and estradiol on BMSC differentiation into osteoblastic lineages. Biochem Cell Biol, 2006; 84(1): 93-101.
31. Post S, Abdallah BM, Bentzon JF, Kassem M: Demonstration of the presence of independent pre-osteoblastic and pre-adipocytic cell populations in bone marrow-derived mesenchymal stem cells. Bone, 2008; 43: 32-39.
32. Okazaki R, Inoue D, Shibata M et al: Estrogen promotes early osteoblast differentiation and inhibits adipocyte differentiation in mouse bone marrow stromal cell lines that express estrogen receptor (ER) alpha or beta. Endocrinology, 2002; 143: 2349-56.
33. Guerkov HH, Lohmann CH, Liu Y et al: Pulsed electromagnetic fields increase growth factor release by nonunion cells. Clin Orthop Relat Res, 2001; (384): 265-79.
34. Ongaro A, Pellati A, Bagheri L et al: Pulsed electromagnetic fields stimulate osteogenic differentiation in human bone marrow and adipose tissue derived mesenchymal stem cells. Bioelectromagnetics, 2014; 35: 426-36.
35. Tsai MT, Li WJ, Tuan RS, Chang WH: Modulation of osteogenesis in human mesenchymal stem cells by specific pulsed electromagnetic field stimulation. J Orthop Res, 2009; 27: 1169-74.
36. Simmons JW Jr., Mooney V, Thacker I: Pseudarthrosis after lumbar spine fusion: nonoperative salvage with pulsed electromagnetic fields. Am J Orthop, 2004; 33: 27-30.
37. Fu YC, Lin CC, Chang JK et al: A novel single pulsed electromagnetic field stimulates osteogenesis of bone marrow mesenchymal stem cells and bone repair. PloS One, 2014; 9: e91581.
38. Sun LY, Hsieh DK, Lin PC et al: Pulsed electromagnetic fields accelerate proliferation and osteogenic gene expression in human bone marrow mesenchymal stem cells during osteogenic differentiation. Bioelectromagnetics, 2010; 31: 209-19.
39. Androjna C, Fort B, Zborowski M, Midura RJ: Pulsed electromagnetic field treatment enhances healing callus biomechanical properties in an animal model of osteoporotic fracture. Bioelectromagnetics, 2014; 35: 396-405.
40. Shen WW, Zhao JH: Pulsed electromagnetic fields stimulation affects BMD and local factor production of rats with disuse osteoporosis. Bioelectromagnetics, 2010; 31: 113-19.
41. Takayama K, Nomura H, Tanaka J et al: Effect of a pulsing electromagnetic field on metabolically derived osteoporosis in rats: A pilot study. ASAIO Trans, 1990; 36: M426-28.
42. Garland DE, Adkins RH, Matsuno NN, Stewart CA: The effect of pulsed electromagnetic fields on osteoporosis at the knee in individuals with spinal cord injury. J Spinal Cord Med, 1999; 22: 239-45.
43. Tabrah F, Hoffmeier M, Gilbert F Jr. et al: Bone density changes in osteoporosis-prone women exposed to pulsed electromagnetic fields (PEMFs). J Bone Minre Res, 1990; 5: 437-42.
44. Yeung DK, Griffith JF, Antonio GE et al: Osteoporosis is associated with increased marrow fat content and decreased marrow fat unsaturation: A proton MR spectroscopy study. J Magn Reson Imaging, 2005; 22: 279-85.
45. Nuttall ME, Gimble JM: Controlling the balance between osteoblastogen- esis and adipogenesis and the consequent therapeutic implications. Curr Opinion Pharmacol, 2004; 4: 290-94.
46. Thompson DL, Lum KD, Nygaard SC et al: The derivation and characterization of stromal cell lines from the bone marrow of p53-/- mice: new insights into osteoblast and adipocyte differentiation. J Bone Miner Res, 1998; 13: 195-204.
47. Verma S, Rajaratnam JH, Denton J et al: Adipocytic proportion of bone marrow is inversely related to bone formation in osteoporosis. J Clin Pathol, 2002; 55: 693-98.
48. Clabaut A, Delplace S, Chauveau C et al: Human osteoblasts derived from mesenchymal stem cells express adipogenic markers upon coculture with bone marrow adipocytes. Differentiation, 2010; 80: 40-45.
49. Zhao JW, Gao ZL, Mei H et al: Differentiation of human mesenchymal stem cells: the potential mechanism for estrogen-induced preferential osteoblast versus adipocyte differentiation. Am J Med Sci, 2011; 341: 460-68.
50. Vassilopoulou-Sellin R: Breast cancer and hormonal replacement therapy. Ann NY Acad Sci, 2003; 997: 341-50.
51. Rossouw JE, Anderson GL, Prentice RL et al: Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women’s Health Initiative randomized controlled trial. JAMA, 2002; 288: 321-33.
52. Weinstein RS: Glucocorticoid-induced osteonecrosis. Endocrine, 2012; 41: 183-90.
53. Zhuang H, Zhang X, Zhu C et al: Molecular mechanisms of PPAR-gamma governing MSC osteogenic and adipogenic differentiation. Curr Stem Cell Res Ther, 2015 [Epub ahead of print].
54. Kelly KA, Gimble JM: 1,25-Dihydroxy vitamin D3 inhibits adipocyte differentiation and gene expression in murine bone marrow stromal cell clones and primary cultures. Endocrinology, 1998; 139: 2622-28.
55. Duque G, Macoritto M, Kremer R: 1,25(OH)2D3 inhibits bone marrow adipo- genesis in senescence accelerated mice (SAM-P/6) by decreasing the expression of peroxisome proliferator-activated receptor gamma 2 (PPARgamma2). Exp Gerontol, 2004; 39: 333-38.
56. Zhang H, Recker R, Lee WN, Xiao GG: Proteomics in bone research. Expert Rev Proteomics, 2010; 7: 103-11.
57. Bornes TD, Jomha NM, Mulet-Sierra A, Adesida AB: Hypoxic culture of bone marrow-derived mesenchymal stromal stem cells differentially enhances in vitro chondrogenesis within cell-seeded collagen and hyaluronic acid porous scaffolds. Stem Cell Res Ther, 2015; 6: 84.
58. Ichioka N, Inaba M, Kushida T et al: Prevention of senile osteoporosis in SAMP6 mice by intrabone marrow injection of allogeneic bone marrow cells. Stem Cells, 2002; 20: 542-51.
59. Justesen J, Stenderup K, Kassem MS: [Mesenchymal stem cells. Potential use in cell and gene therapy of bone loss caused by aging and osteoporosis]. Ugeskr Laeger, 2001; 163(40): 5491-95 [in Danish].
60. Ocarino Nde M, Boeloni JN, Jorgetti V et al: Intra-bone marrow injection of mesenchymal stem cells improves the femur bone mass of osteoporotic female rats. Connect Tiss Res, 2010; 51: 426-33.
61. Wang Z, Goh J, Das De S et al: Efficacy of bone marrow-derived stem cells in strengthening osteoporotic bone in a rabbit model. Tissue Eng, 2006; 12:1753-61.
62. Okamoto Y, Tateishi H, Kinoshita K et al: An experimental study of bone healing around the titanium screw implants in ovariectomized rats: Enhancement of bone healing by bone marrow stromal cells transplantation. Implant Dent, 2011; 20: 236-45.
63. Ma XW, Cui DP, Zhao DW: Vascular endothelial growth factor/bone morphogenetic protein-2 bone marrow combined modification of the mesenchymal stem cells to repair the avascular necrosis of the femoral head. Int J Clin Exp Med, 2015; 8: 15528-34.
64. Cheng TL, Schindeler A, Little DG: BMP-2 delivered via sucrose acetate iso- butyrate (SAIB) improves bone repair in a rat open fracture model. J Orthop Res, 2015 [Epub ahead of print].
65. Wikesjo UM, Qahash M, Thomson RC et al: rhBMP-2 significantly enhances guided bone regeneration. Clin Oral Implant Res, 2004; 15: 194-204.
66. Zhao T, Zhang D, Millard RW et al: Stem cell homing and angiomyogene- sis in transplanted hearts are enhanced by combined intramyocardial SDF- 1alpha delivery and endogenous cytokine signaling. Am J Physiol Heart Circ Physiol, 2009; 296(4): H976-86.
67. Kimura Y, Tabata Y: Controlled release of stromal-cell-derived factor-1 from gelatin hydrogels enhances angiogenesis. J Biomater Sci Polym Ed, 2010; 21(1): 37-51.
68. Otsuru S, Tamai K, Yamazaki T et al: Circulating bone marrow-derived osteoblast progenitor cells are recruited to the bone-forming site by the CXCR4/ stromal cell-derived factor-1 pathway. Stem Cells, 2008; 26: 223-34.
69. Kortesidis A, Zannettino A, Isenmann S et al: Stromal-derived factor-1 promotes the growth, survival, and development of human bone marrow stromal stem cells. Blood, 2005; 105: 3793-801.
70. Boilly B, Vercoutter-Edouart AS, Hondermarck H et al: FGF signals for cell proliferation and migration through different pathways. Cytokine Growth Factor Rev, 2000; 11: 295-302.
71. Yuan Q, Kubo T, Doi K et al: Effect of combined application of bFGF and inorganic polyphosphate on bioactivities of osteoblasts and initial bone regeneration. Acta Biomater, 2009; 5: 1716-24.
72. Martin I, Muraglia A, Campanile G et al: Fibroblast growth factor-2 supports ex vivo expansion and maintenance of osteogenic precursors from human bone marrow. Endocrinology, 1997; 138: 4456-62.
73. Parikh SN: Gene therapy: Principles and clinical applications in orthopedics. Orthopedics, 2004; 27: 294-303, 304-5.
74. Pelled G G T, Aslan H. et al.: Mesenchymal stem cells for bone gene therapy and tissue engineering. Curr Pharm Des, 2002; 8: 1917-28.
75. Centeno CJ, Busse D, Kisiday J et al: Increased knee cartilage volume in degenerative joint disease using percutaneously implanted, autologous mesenchymal stem cells. Pain Physician, 2008; 11: 343-53.
76. Kumar S, Mahendra G, Nagy TR, Ponnazhagan S: Osteogenic differentiation of recombinant adeno-associated virus 2-transduced murine mesenchymal stem cells and development of an immunocompetent mouse model for ex vivo osteoporosis gene therapy. Hum Gene Ther, 2004; 15: 1197-206.
77. Baltzer AW, Whalen JD, Wooley P et al: Gene therapy for osteoporosis: evaluation in a murine ovariectomy model. Gene Ther, 2001; 8: 1770-76.
78. Lien CY, Chih-Yuan Ho K, Lee OK et al: Restoration of bone mass and strength in glucocorticoid-treated mice by systemic transplantation of CXCR4 and cbfa-1 co-expressing mesenchymal stem cells. J Bone Miner Res, 2009; 24: 837-48.
79. Li HC, Stoicov C, Rogers AB, Houghton J: Stem cells and cancer: evidence for bone marrow stem cells in epithelial cancers. World J Gastroenterol, 2006; 12: 363-71.
80. Werbowetski-Ogilvie TE, Bosse M, Stewart M et al: Characterization of human embryonic stem cells with features of neoplastic progression. Nat Biotechnol, 2009; 27: 91-97.
81. Kang MI, Lee WY, Oh KW et al: The short-term changes of bone mineral metabolism following bone marrow transplantation. Bone, 2000; 26: 275-79.
82. Singh SP, Chang EI, Gossain AK et al: Cyclic mechanical strain increases production of regulators of bone healing in cultured murine osteoblasts. J Am Coll Surg, 2007; 204: 426-34.
83. Rath B, Nam J, Knobloch TJ et al: Compressive forces induce osteogenic gene expression in calvarial osteoblasts. J Biomech, 2008; 41: 1095-103.